Single-level cervical arthroplasty with ProDisc-C artificial disc: 10-year follow-up results in one centre
The aim of this study was to evaluate the long-term clinical and radiographic outcomes of cervical arthroplasty using the ProDisc-C prosthesis.
Clinical and radiographic evaluations, including dynamic flexion–extension lateral images, were performed at baseline and at 10-year follow-up.
Twenty-seven patients who had single-level ProDisc-C arthroplasty were followed up for a mean period of 123 months. The range of motion at the operated level was 8.9° ± 3.9° at baseline and 6.6° ± 3.5° at final follow-up. Twenty of 27 levels (74%) developed heterotopic ossification. According to McAfee’s classification, one level was classified as grade I, four levels were classified as grade II, 12 levels were classified as grade III and three levels were classified as grade IV. Three patients developed recurrent cervical radiculopathy or myelopathy due to adjacent segment disease and received the reoperations. The reoperations included two cases of cervical arthroplasty at adjacent segments and one case of cervical laminoplasty.
ProDisc-C arthroplasty had acceptable clinical and radiographic results at 10-year follow-up. Heterotopic ossification was common after ProDisc-C arthroplasty, which decreased the range of motion.
These slides can be retrieved under Electronic Supplementary Material.
KeywordsCervical disc arthroplasty Heterotopic ossification Adjacent segment disease
No fund received.
Compliance with ethical standards
Conflict of interest
- 1.Zigler JE, Delamarter R, Murrey D, Spivak J, Janssen M (2013) ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study. Spine (Phila Pa 1976) 38:203–209. https://doi.org/10.1097/BRS.0b013e318278eb38 CrossRefGoogle Scholar
- 2.Janssen ME, Zigler JE, Spivak JM, Delamarter RB, Darden BV 2nd, Kopjar B (2015) ProDisc-C total disc replacement versus anterior cervical discectomy and fusion for single-level symptomatic cervical disc disease: seven-year follow-up of the prospective randomized U.S. Food and Drug Administration investigational device exemption study. J Bone Joint Surg Am 97:1738–1747. https://doi.org/10.2106/JBJS.N.01186 CrossRefGoogle Scholar
- 6.Loumeau TP, Darden BV, Kesman TJ, Odum SM, Van Doren BA, Laxer EB, Murrey DB (2016) A RCT comparing 7-year clinical outcomes of one level symptomatic cervical disc disease (SCDD) following ProDisc-C total disc arthroplasty (TDA) versus anterior cervical discectomy and fusion (ACDF). Eur Spine J 25:2263–2270. https://doi.org/10.1007/s00586-016-4431-6 CrossRefGoogle Scholar
- 9.Murrey D, Janssen M, Delamarter R, Goldstein J, Zigler J, Tay B, Darden B (2009) Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease. Spine J 9:275–286. https://doi.org/10.1016/j.spinee.2008.05.006 CrossRefGoogle Scholar
- 10.Mehren C, Suchomel P, Grochulla F, Barsa P, Sourkova P, Hradil J, Korge A, Mayer HM (2006) Heterotopic ossification in total cervical artificial disc replacement. Spine (Phila Pa 1976) 31:2802–2806. https://doi.org/10.1097/01.brs.0000245852.70594.d5 CrossRefGoogle Scholar
- 12.Zhao YB, Sun Y, Zhou FF, Liu ZJ (2013) Cervical disc arthroplasty with ProDisc-C artificial disc: 5-year radiographic follow-up results. Chin Med J (Engl) 126:3809–3811Google Scholar
- 18.Brenke C, Scharf J, Schmieder K, Barth M (2012) High prevalence of heterotopic ossification after cervical disc arthroplasty: outcome and intraoperative findings following explantation of 22 cervical disc prostheses. J Neurosurg Spine 17:141–146. https://doi.org/10.3171/2012.4.SPINE12223 CrossRefGoogle Scholar